100 related articles for article (PubMed ID: 9126892)
1. Intravenous insulin-like growth factor-I (IGF-I) in moderate-to-severe head injury: a phase II safety and efficacy trial.
Hatton J; Rapp RP; Kudsk KA; Brown RO; Luer MS; Bukar JG; Chen SA; McClain CJ; Gesundheit N; Dempsey RJ; Young B
J Neurosurg; 1997 May; 86(5):779-86. PubMed ID: 9126892
[TBL] [Abstract][Full Text] [Related]
2. Intravenous insulin-like growth factor-I (IGF-I) in moderate-to-severe head injury: a Phase II safety and efficacy trial.
Hatton J; Rapp RP; Kudsk KA; Brown RO; Luer MS; Bukar JG; Chen SA; McClain CJ; Gesundheit N; Dempsey RJ; Young B
Neurosurg Focus; 1997 May; 2(5):ECP1; discussion 1 p following ECP1. PubMed ID: 15096005
[TBL] [Abstract][Full Text] [Related]
3. Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury.
Hatton J; Kryscio R; Ryan M; Ott L; Young B
J Neurosurg; 2006 Dec; 105(6):843-52. PubMed ID: 17405254
[TBL] [Abstract][Full Text] [Related]
4. Nutritional support and measured energy expenditure of the child and adolescent with head injury.
Phillips R; Ott L; Young B; Walsh J
J Neurosurg; 1987 Dec; 67(6):846-51. PubMed ID: 3119794
[TBL] [Abstract][Full Text] [Related]
5. Propofol in the treatment of moderate and severe head injury: a randomized, prospective double-blinded pilot trial.
Kelly DF; Goodale DB; Williams J; Herr DL; Chappell ET; Rosner MJ; Jacobson J; Levy ML; Croce MA; Maniker AH; Fulda GJ; Lovett JV; Mohan O; Narayan RK
J Neurosurg; 1999 Jun; 90(6):1042-52. PubMed ID: 10350250
[TBL] [Abstract][Full Text] [Related]
6. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans.
Clemmons DR; Smith-Banks A; Underwood LE
J Clin Endocrinol Metab; 1992 Jul; 75(1):234-8. PubMed ID: 1619015
[TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant human insulin-like growth factor I and early total parenteral nutrition on immune depression following severe head injury.
Kudsk KA; Mowatt-Larssen C; Bukar J; Fabian T; Oellerich S; Dent DL; Brown R
Arch Surg; 1994 Jan; 129(1):66-70; discussion 70-1. PubMed ID: 8279942
[TBL] [Abstract][Full Text] [Related]
8. Effects of therapeutic hypothermia on intracranial pressure and outcome in patients with severe head injury.
Polderman KH; Tjong Tjin Joe R; Peerdeman SM; Vandertop WP; Girbes AR
Intensive Care Med; 2002 Nov; 28(11):1563-73. PubMed ID: 12415442
[TBL] [Abstract][Full Text] [Related]
9. The effect of nutritional support on outcome from severe head injury.
Young B; Ott L; Twyman D; Norton J; Rapp R; Tibbs P; Haack D; Brivins B; Dempsey R
J Neurosurg; 1987 Nov; 67(5):668-76. PubMed ID: 3117982
[TBL] [Abstract][Full Text] [Related]
10. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.
Clemmons DR; Moses AC; McKay MJ; Sommer A; Rosen DM; Ruckle J
J Clin Endocrinol Metab; 2000 Apr; 85(4):1518-24. PubMed ID: 10770191
[TBL] [Abstract][Full Text] [Related]
11. Effect of THAM upon outcome in severe head injury: a randomized prospective clinical trial.
Wolf AL; Levi L; Marmarou A; Ward JD; Muizelaar PJ; Choi S; Young H; Rigamonti D; Robinson WL
J Neurosurg; 1993 Jan; 78(1):54-9. PubMed ID: 8416243
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid and serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in patients with severe head injury.
Sanus GZ; Tanriverdi T; Coşkun A; Hanimoğlu H; Is M; Uzan M
Ulus Travma Acil Cerrahi Derg; 2007 Oct; 13(4):281-7. PubMed ID: 17978909
[TBL] [Abstract][Full Text] [Related]
13. Enteral hyperalimentation in head injury.
Clifton GL; Robertson CS; Contant CF
J Neurosurg; 1985 Feb; 62(2):186-93. PubMed ID: 3918145
[TBL] [Abstract][Full Text] [Related]
14. [Effects of probiotics on blood glucose levels and clinical outcomes in patients with severe craniocerebral trauma].
Tan M; Lu XL; Duan JW; Peng H; Zhu JC
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Oct; 25(10):627-30. PubMed ID: 24119702
[TBL] [Abstract][Full Text] [Related]
15. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism.
Murphy MG; Plunkett LM; Gertz BJ; He W; Wittreich J; Polvino WM; Clemmons DR
J Clin Endocrinol Metab; 1998 Feb; 83(2):320-5. PubMed ID: 9467534
[TBL] [Abstract][Full Text] [Related]
16. Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome.
Lieberman SA; Butterfield GE; Harrison D; Hoffman AR
J Clin Endocrinol Metab; 1994 Feb; 78(2):404-10. PubMed ID: 7508949
[TBL] [Abstract][Full Text] [Related]
17. The favorable effect of early parenteral feeding on survival in head-injured patients.
Rapp RP; Young B; Twyman D; Bivins BA; Haack D; Tibbs PA; Bean JR
J Neurosurg; 1983 Jun; 58(6):906-12. PubMed ID: 6406649
[TBL] [Abstract][Full Text] [Related]
18. Analysis of long-term (median 10.5 years) outcomes in children presenting with traumatic brain injury and an initial Glasgow Coma Scale score of 3 or 4.
Fulkerson DH; White IK; Rees JM; Baumanis MM; Smith JL; Ackerman LL; Boaz JC; Luerssen TG
J Neurosurg Pediatr; 2015 Oct; 16(4):410-9. PubMed ID: 26140392
[TBL] [Abstract][Full Text] [Related]
19. Zinc supplementation is associated with improved neurologic recovery rate and visceral protein levels of patients with severe closed head injury.
Young B; Ott L; Kasarskis E; Rapp R; Moles K; Dempsey RJ; Tibbs PA; Kryscio R; McClain C
J Neurotrauma; 1996 Jan; 13(1):25-34. PubMed ID: 8714860
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of neuron-specific enolase in head trauma patients.
Meric E; Gunduz A; Turedi S; Cakir E; Yandi M
J Emerg Med; 2010 Apr; 38(3):297-301. PubMed ID: 18499387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
